Combination of Curcumin and Zerumbone Improves VEGF-A Inhibition in Colorectal Cancer In Vivo and In Vitro Model

Sima Nobari,Razieh Amini,Farid Azizi Jalilian,Rezvan Najafi,Fatemeh Bahreini

DOI: https://doi.org/10.1007/s40011-023-01486-z

2023-05-26

Proceedings of the National Academy of Sciences India Section B - Biological Sciences

Abstract:Colorectal cancer (CRC) is reliant on several molecular pathways, which may develop distinct mechanisms of resistance to single-agent treatment. In vitro and in vivo models of CRC were used to assess the anti-tumorigenic effects of zerumbone (ZER) and curcumin (CUR). Angiogenesis is essential for tumor development and metastasis. The most essential factor in tumor angiogenesis is vascular endothelial growth factor-A (VEGF-A), and the antiangiogenic action of miR-34a in malignancies is well known. ZER, a natural chemical derived from Zingiber zerumbet Smith, was combined with CUR (a yellow pigment derived from Curcuma longa) as a possible anti-tumorigenic treatment for CRC. On CT-26 and SW48 cell lines, the impact of ZER and CUR on cell viability was determined using the MTT test in a dose- and time-dependent manner. Genes' mRNA expression and protein levels were then evaluated using real-time PCR and ELISA. VEGF-A mRNA and protein levels were measured using real-time PCR and immunocytochemistry techniques, respectively. Tumor size was measured after 21 days of therapy in CRC BALB/c mice. In general, we discovered that ZER and CUR significantly decreased VEGF-A and increased miR-34a in CRC cell lines and tumor tissue. mRNA and protein levels were enhanced by the combination of ZER and CUR compared to control groups. The evaluation of tumor size in ZER- and CUR-treated groups revealed a considerable reduction, which was more pronounced in the combination therapy group. Our findings indicated that the combination treatment for CRC was very effective with little toxicity.